|
SARS-CoV-2 Spike 681P
Antibodies (Wild Type: WT) |
|
|
Product |
Cat.
No. |
Application |
Clonality |
Species |
WT |
|
|
SARS-CoV-2 Spike 681P Antibody |
PM-9365 |
E, WB |
Monoclonal |
Mouse |
++++ |
|
|
SARS-CoV-2 Spike 681P Antibody |
PM-9366 |
E, WB |
Monoclonal |
Mouse |
++++ |
|
|
SARS-CoV-2 Spike 681P Antibody |
PM-9367 |
E, WB |
Monoclonal |
Mouse |
++++ |
|
|
|
|
|
|
|
|
|
|
SARS-CoV-2 Alpha Variant (B.1.1.7, U.K.) Specific
Antibodies |
|
|
Product |
Cat.
No. |
Application |
Clonality |
Species |
WT |
|
|
SARS-CoV-2 Alpha Variant
(B.1.1.7, U.K.) Spike P681H Antibody |
9359 |
E, WB |
Polyclonal |
Rabbit |
- |
|
|
SARS-CoV-2
Alpha Variant (B.1.1.7, U.K.) Spike P681H Antibody |
PM-9371 |
E,
WB |
Monoclonal |
Mouse |
- |
|
|
SARS-CoV-2
Alpha Variant (B.1.1.7, U.K.) Spike P681H Antibody |
PM-9373 |
E,
WB |
Monoclonal |
Mouse |
- |
|
|
SARS-CoV-2
Alpha Variant (B.1.1.7, U.K.) Spike P681H Antibody |
PM-9374 |
E,
WB |
Monoclonal |
Mouse |
- |
|
|
SARS-CoV-2
Alpha Variant (B.1.1.7, U.K.) Spike P681H Antibody |
PM-9375 |
E,
WB |
Monoclonal |
Mouse |
- |
|
|
|
|
|
|
|
|
|
|
SARS-CoV-2 Delta Variant Antibodies |
|
|
|
|
|
|
|
Product |
Cat. No. |
Application |
Clonality |
Species |
|
|
|
SARS-CoV-2 (COVID-19) Spike
156-157EF Antibody |
9685 |
E, WB |
Polyclonal |
Mouse |
|
|
|
SARS-CoV-2
(COVID-19) Spike 156-157EFdel Antibody (Delta Variant) |
9689 |
E,
WB |
Polyclonal |
Mouse |
|
|
|
SARS-CoV-2
(COVID-19) Spike L452R Antibody (Delta Variant) |
9463 |
E,
WB |
Polyclonal |
Mouse |
|
|
|
|
|
|
|
|
|
|
|
SARS-CoV-2 Gamma Variant Antibodies |
|
|
|
|
|
|
|
Product |
Cat. No. |
Application |
Clonality |
Species |
|
|
|
SARS-CoV-2 (COVID-19) Spike
P26S Antibody (Gamma Variant) |
9573 |
E, WB |
Polyclonal |
Rabbit |
|
|
|
SARS-CoV-2
(COVID-19) Spike 26P Antibody |
PM-9583 |
E,
WB |
Monoclonal |
Mouse |
|
|
|
SARS-CoV-2
(COVID-19) Spike P26S Antibody (Gamma Variant) |
PM-9590 |
E,
WB |
Monoclonal |
Mouse |
|
|
|
|
|
|
|
|
|
|
|
Other SARS-CoV-2 Variant Related Antibodies |
|
|
Product |
Cat. No. |
WT |
Alpha Variant
(B.1.1.7) |
Beta Variant
(B.1.135) |
Gamma Variant
(P.1) |
Comment |
|
SARS-CoV-2 (COVID-19) Spike S1
Antibody |
9083 |
++++ |
++++ |
++++ |
- |
9083 cannot
detect Brazil Variant |
|
SARS-CoV-2
(COVID-19) Spike S1 Antibody [SP185] |
10-351 |
++++ |
++++ |
- |
- |
10-351
cannot detect S.A. and Brazil Variants |
|
SARS-CoV-2
(COVID-19) Spike S1 Antibody [SP422] |
10-350 |
++++ |
++++ |
++ |
++ |
10-350
has a lower affinity for S.A. and Brazil Variants |
|
SARS-CoV-2
(COVID-19) Spike RBD Antibody |
9087 |
++++ |
+++ |
++ |
+ |
9087
has a lower affinity for all variants |
|
SARS-CoV-2
(COVID-19) Spike S1 Antibody (cleavage) |
9091 |
++++ |
++ |
N/A |
N/A |
9091
has a lower affinity for UK variant |
|
|
|
|
|
|
|
|
|
SARS-CoV-2 Variants
Recombinant Proteins |
|
|
|
|
|
|
Product |
Cat. No. |
Source |
Fusion Tag |
Sequence |
|
SARS-CoV-2 (COVID-19) Alpha S
RBD RP |
11-064 |
Mammalian Cells |
C-His |
N501Y |
|
SARS-CoV-2
(COVID-19) Beta S RBD RP |
11-065 |
Mammalian
Cells |
C-His |
K417N, E484K, N501Y |
|
SARS-CoV-2
(COVID-19) Gamma S RBD RP |
11-066 |
Mammalian
Cells |
C-His |
E484K, K417T, N501Y |
|
Delta Variant
Spike S1 Recombinant Protein (His-Avi tag) |
95-127 |
HEK293
cells |
C-His |
Val 16 - Arg 685 (T19R, G142D, EF156-157del, R158G, L452R,
T478K, D614G, P681R)-His-Avi |
|
SARS-CoV-2
(COVID-19) Alpha/Beta Spike Trimer |
11-067 |
Mammalian
Cells |
C-His |
E484K |
|
SARS-CoV-2
(COVID-19) D614G Spike RP |
92-748 |
Human
Cells |
C-His |
D614G |
|
SARS-CoV-2
(COVID-19) D614G Spike S1 RP |
92-746 |
Human
Cells |
C-His |
D614G |
|
SARS CoV-2
spike protein in LMNG detergent |
21-815 |
HEK293 |
C-Terminal
Rho1D4 |
AA 1-1273 |
|
SARS CoV-2
spike protein in DIBMA Glycerol |
21-816 |
HEK293 |
C-Terminal
Rho1D4 |
AA 1-1273 |
|
SARS CoV-2
spike protein nanodisc complex |
21-817 |
HEK293 |
C-Terminal
Rho1D4 |
AA 1-1273 |
|
SARS-CoV-2
(COVID-19) full-length Spike S1 Alpha (United Kingdom, Sept 2020) B.1.1.7
Variant RP |
21-818 |
HEK293 |
C-Terminal
Rho1D4 |
AA 1-1273 |
|
SARS-CoV-2
(COVID-19) full-length Spike S1 Beta (South Africa, May 2020) B.1.351 Variant
RP |
21-819 |
HEK293 |
C-Terminal
Rho1D4 |
Del 144; K417N; E484K; N501Y; A570D; D614G; P681H; T716I; S982A;
D1118H; more… |
|
SARS-CoV-2
(COVID-19) full-length Spike S1 Gamma (Brazil, Nov 2020) P.1 Variant RP |
21-820 |
HEK293 |
C-Terminal
Rho1D4 |
AA 1-1273 |
|
SARS-CoV-2
(COVID-19) full-length Spike S1 Eta (United Kingdom, Dec 2020) B.1.525
Variant RP |
21-821 |
HEK293 |
C-Terminal
Rho1D4 |
AA 1-1273 |
|
SARS-CoV-2
(COVID-19) full-length Spike S1 Epsilon (California) B.1.429 Variant RP |
21-822 |
HEK293 |
C-Terminal
Rho1D4 |
AA 1-1273 |
|
SARS-CoV-2
(COVID-19) full-length Spike S1 Kappa (India, Dec 2020) B.1.617.1 Variant RP |
21-823 |
HEK293 |
C-Terminal
Rho1D4 |
AA 1-1273 |
|
SARS-CoV-2
(COVID-19) Spike RBD Alpha (United Kingdom, Sept 2020) B.1.1.7 Variant RP |
21-824 |
HEK293 |
C-Terminal
His Tag |
AA 319-537 (N501Y) |
|
SARS-CoV-2
(COVID-19) Spike RBD Beta (South Africa, May 2020) B.1.351 Variant RP |
21-825 |
HEK293 |
C-Terminal
His Tag |
AA 319-537 (N501Y) |
|
SARS-CoV-2
(COVID-19) Spike RBD Gamma (Brazil, Nov 2020) P.1 Variant RP |
21-826 |
HEK293 |
C-Terminal
His Tag |
AA 319-537 (K417T; E484K; N501Y) |